SEC Filing Analysis: Surrozen, Inc./DE (SRZN)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An executive acquired a small number of shares through a routine Employee Stock Purchase Plan (ESPP), a transaction with minimal market signaling value.
• Market Impact: Neutral, as the transaction is minor relative to the company's market capitalization and is not an open-market purchase.

Company Information

Field	Value
Company	Surrozen, Inc./DE
Ticker Symbol	SRZN
CIK	0001824893
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Li Yang
CIK	0001990537
Title/Position	Exec. Vice President, Research
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-15
Transaction Code	A (Award)
Security Type	Common Stock
Shares Involved	1,666
Price Per Share	$8.11
Total Value	$13,507.26
Shares Owned After	14,709
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$13,507.26
% of Market Cap	0.012%
Shares Transacted	1,666
% of Shares Outstanding	Not Available
Post-Transaction Ownership	14,709 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction's value of ~$13.5k is negligible compared to Surrozen's $110 million market capitalization.
• Transaction Significance: The transaction is considered low significance due to its small size (0.012% of market cap) and its nature as a pre-planned ESPP acquisition rather than a discretionary open-market trade.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Employee stock purchases are common and do not typically reflect an insider's specific outlook on the company's near-term performance. The size of the transaction is too small to be material.

Volume & Sentiment

• Expected Volume Impact: Negligible. This transaction is unlikely to have any noticeable effect on trading volume.
• Sentiment Indicator: Neutral. The market generally does not react to small, routine ESPP acquisitions.

Additional Context

Transaction Notes

• Special Circumstances: The filing footnote clarifies that these shares were acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan and are exempt transactions.